New global Alzheimer’s disease country insights tool reveals major inequalities in diagnosis, treatment access and preparedness across countries

Alzheimer’s Disease International (ADI) has launched the Alzheimer’s Disease Atlas (AD Atlas), a first of its kind platform highlighting how countries diagnose, treat and support people living with dementia. The platform brings together the key indicators needed to assess a country’s preparedness for Alzheimer’s disease and related dementias, helping advocates, policymakers and healthcare leaders identify where people are being left behind.

The AD Atlas, supported by Eli Lilly and Company, shows that people living with dementia can face very different experiences of diagnosis, care and support depending on where they live. Key findings include:

The AD Atlas reveals not only the scale of the global disparity, but the systemic gaps that continue to fail people living with dementia and their families.

While wealthier countries tend to be better equipped, economic strength does not necessarily translate into readiness. Even some of the world’s richest nations are failing to prepare for the projected rise in dementia over the next two decades, with the number of people living with the condition expected to double.